1. Market Research
  2. > Healthcare
  3. > Pathology
  4. > Cancer Market Trends
  5. > Prostate Cancer Partnering 2010-2015

Prostate Cancer Partnering 2010-2015

  • March 2015
  • -
  • Currentpartnering
  • -
  • 150 pages

The Prostate cancer Partnering 2010-2015 report provides understanding and access to the prostate cancer partnering deals and agreements entered into by the worlds leading healthcare companies.

Trends in prostate cancer partnering deals
Top prostate cancer deals by value
Deals listed by company A-Z, industry sector, stage of development, technology type

The Prostate cancer Partnering 2010-2015 provides understanding and access to the prostate cancer partnering deals and agreements entered into by the worlds leading healthcare companies.

The report provides an analysis of prostate cancer partnering deals. The majority of deals are discovery or development stage whereby the licensee obtains a right or an option right to license the licensors prostate cancer technology. These deals tend to be multicomponent, starting with collaborative R&D, and commercialization of outcomes.

Understanding the flexibility of a prospective partner’s negotiated deals terms provides critical insight into the negotiation process in terms of what you can expect to achieve during the negotiation of terms. Whilst many smaller companies will be seeking details of the payments clauses, the devil is in the detail in terms of how payments are triggered – contract documents provide this insight where press releases do not.

This data driven report contains over 200 links to online copies of actual prostate cancer deals and contract documents as submitted to the Securities Exchange Commission by companies and their partners, where available. Contract documents provide the answers to numerous questions about a prospective partner’s flexibility on a wide range of important issues, many of which will have a significant impact on each party’s ability to derive value from the deal.

The initial chapters of this report provide an orientation of prostate cancer partnering trends.

Chapter 1 provides an introduction to the report, whilst chapter 2 provides an overview of the trends in partnering since 2010, including a summary of deals by industry sector, stage of development, deal type, and technology type.

Chapter 3 provides an overview of the average deal terms since 2010. The chapter includes deals with a stage of development announced by headline value, upfront value, milestone value and royalty rate. Numerous tables outline financial trends.

Chapter 4 provides an overview of the most active dealmakers, top dealmakers by value, active big pharma and big biotech dealmakers including contract documents where available.

Chapter 5 provides a comprehensive directory of partnering deals signed and announced since 2010. The chapter is organized by company A-Z, stage of development at signing, deal type (collaborative R&D, co-promotion, licensing etc), and technology type. Each deal title links via Weblink to an online version of the deal record, and where available the contract document, providing easy access to each contract document on demand.

In conclusion, this report provides everything a prospective dealmaker needs to know about partnering in the research, development and commercialization of bladder cancer technologies and products.

Report scope

Prostate cancer Partnering 2010-2015 is intended to provide the reader with an in-depth understanding and access to prostate cancer trends and structure of deals entered into by leading companies worldwide.

This data driven report includes:

Trends in prostate cancer dealmaking in the biopharma industry since 2010
Access to summary headline, upfront, milestone and royalty data
Access to over 100 prostate cancer deals and contract documents where available
The leading prostate cancer deals by value since 2010

In Prostate cancer Partnering 2010-2015, the available deals are listed by:

Headline value
Upfront payment value
Royalty rate value
Company A-Z
Industry sector
Stage of development at signing
Deal component type
Technology type

Each deal title links via Weblink to an online version of the deal record and where available, the contract document, providing easy access to each contract document on demand.

Table Of Contents

Prostate Cancer Partnering 2010-2015
Executive Summary

Chapter 1 - Introduction

Chapter 2 - Trends in Prostate cancer partnering

2.1. Introduction
2.2. Prostate cancer partnering over the years
2.3. Prostate cancer partnering by deal type
2.4. Prostate cancer partnering industry sector
2.5. Prostate cancer partnering by stage of development
2.6. Prostate cancer partnering by technology type

Chapter 3 - Average deal terms for Prostate cancer

3.1 Introduction
3.2 Average deal terms for Prostate cancer
3.3 Prostate cancer headline values with median calculation
3.4 Prostate cancer upfront values with median calculation
3.5 Prostate cancer milestone values with median calculation
3.6 Prostate cancer royalty rates with median calculation

Chapter 4 - Active Prostate cancer dealmakers

4.1. Introduction
4.2 Most active Prostate cancer dealmakers
4.3. Top Prostate cancer deals by value
4.4 Big pharma deal activity
4.5 Big biotech deal activity

Chapter 5 - Prostate cancer dealmaking directory

5.1. Introduction
5.2. Company A-Z
5.3. By deal type
5.4. By industry sector
5.5. By stage of development
5.6. By technology type

Chapter 6 - Partnering resource center

6.1. Online partnering
6.2. Partnering events
6.3. Further reading on dealmaking

Appendices

Appendix 1 - Deal type definitions

About Wildwood Ventures

Current Partnering
Current Agreements
Recent report titles from Current Partnering
Order Form - Reports
Order Form - Subscription Access Products

Table of figures

Figure 1: Prostate cancer partnering since 2010
Figure 2: Prostate cancer dealmaking activity- 2010 to 2015
Figure 3: Prostate cancer partnering by deal type since 2010
Figure 4: Prostate cancer partnering by industry sector since 2010
Figure 5: Prostate cancer partnering by stage of development since 2010
Figure 6: Prostate cancer partnering by technology type since 2010
Figure 7: Prostate cancer deals with a headline value
Figure 8: Prostate cancer deals with upfront payment values
Figure 9: Prostate cancer deals with milestone payments
Figure 10: Prostate cancer deals with royalty rates, %
Figure 11: Top Prostate cancer deals by value since 2010
Figure 12: Big pharma - top 50 - Prostate cancer deals 2010 to 2015
Figure 13: Big pharma Prostate cancer deal frequency - 2010 to 2015
Figure 14: Big biotech - top 50 - Prostate cancer deals 2010 to 2015
Figure 15: Big biotech Prostate cancer deal frequency - 2010 to 2015
Figure 16: Online partnering resources
Figure 17: Forthcoming partnering events
Figure 18: Deal type definitions

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
Prostate Cancer: Analytical Tool

Prostate Cancer: Analytical Tool

  • $ 8096
  • Industry report
  • August 2016
  • by Bioseeker

Analytical Tools are cancer area specific intelligence and surveillance toolkits within a select number of hot, emerging cancer therapy areas. They are designed to empower biotech/pharma professionals ...

Epiomic Epidemiology Series: Prostate Cancer Forecast in 18 Major Markets 2016-2026

Epiomic Epidemiology Series: Prostate Cancer Forecast in 18 Major Markets 2016-2026

  • $ 5112
  • Industry report
  • September 2016
  • by Black Swan Analysis Ltd132

Black Swan Analysis Epiomic™ Epidemiology Series Forecast Report on Prostate Cancer in 18 Major Markets Prostate cancer is one of the most common cancers in men. The prostate, found only in men, is the ...

Prostate cancer- Market Insights, Epidemiology and Market Forecast-2023

Prostate cancer- Market Insights, Epidemiology and Market Forecast-2023

  • $ 4950
  • Industry report
  • November 2016
  • by Delve Insight

Note*: This report requires 5 business days to complete. DelveInsight’s Prostate cancer - Market Insights, Epidemiology and Market Forecast-2023” Reports provides an overview of the disease and global ...


Download Unlimited Documents from Trusted Public Sources

Cancer Statistics in the UK

  • December 2016
    20 pages
  • Cancer  

  • United Kingdom  

    Europe  

View report >

Prostate Cancer Statistics and Therapy Market in the US

  • November 2016
    7 pages
  • Prostate Cancer  

    Therapy  

  • United States  

View report >

Cancer Statistics in Europe

  • November 2016
    16 pages
  • Colorectal Canc...  

    Breast Cancer  

    Cancer  

  • Europe  

View report >

Related Market Segments :

Prostate Cancer

ref:plp2015

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.